# Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

> **NCT02548455** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 499 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Quartet 1457Q LV Lead

## Key facts

- **NCT ID:** NCT02548455
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-27
- **Primary completion:** 2016-08-19
- **Final completion:** 2017-03-21
- **Target enrollment:** 499 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548455, "Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02548455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*